The purpose of this study is to determine whether CP-741,952 is effective in the treatment of
obesity and to determine 12 week safety and toleration.
- BMI of 30-40 kg/m2
- Women of childbearing potential
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: